Founded in 2008, our mission is simple and urgent:
Make medicine more effective and less toxic.
WHAT WE DO:
We use bioconjugation to attach therapeutic cargos to targeting molecules — creating AqT Therapeutics like antibody-drug conjugates (ADC) that find diseased cells while sparing healthy ones.
- Precision targeting
- Fewer side effects
- Enhanced drug efficacy
- New treatment possibilities
 |
 |
Years of Innovation in Bioconjugation and Linker Technologies With proprietary linkers, advanced conjugation methods, and integrated platforms.